StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2021 - 04 - 30
10
2021 - 04 - 29
1
Sector
Health technology
10
Producer manufacturing
1
Tags
Alliances
1
Application
1
Biotech
1
Car-t
1
Cel
1
Clinical-trials-phase-ii
1
Covid
1
Cystic fibrosis
1
Designation
2
Disease
2
Distribution
1
Drug
3
Dry eye
1
Duchenne
1
Europe
1
Events
1
Eye
1
Eye disease
1
Fibrosis
1
Food
2
Gene therapies
1
Gene therapy
1
Growth
1
Immunotherapy
1
Iot
1
N/a
6
Neurological
1
Nivolumab
1
Ongoing
1
Pharm-country
1
Phase 2
2
Product-news
1
Submission
1
Therapy
3
Treatment
11
Trial
1
Urothelial carcinoma
1
Entities
Abbvie inc.
1
Astrazeneca plc
1
Bristol-myers squibb company
1
Eloxx pharmaceuticals, inc.
1
Glaxosmithkline plc
2
Johnson & johnson
1
Lantheus holdings, inc.
1
Legend biotech corporation
1
Novartis ag
2
Praxis precision medicines, inc.
2
Sanofi
1
Sarepta therapeutics, inc.
1
Xylem inc.
1
Symbols
ABBV
1
AZN
1
BMY
1
ELOX
1
GSK
2
JNJ
1
LEGN
1
LNTH
1
NVS
2
PRAX
2
SNY
1
SRPT
1
XYL
1
Exchanges
Nasdaq
8
Nyse
5
Crawled Date
2024 - 03 - 19
12
2024 - 03 - 05
12
2024 - 03 - 04
13
2023 - 12 - 12
13
2023 - 12 - 06
15
2023 - 11 - 27
14
2023 - 10 - 23
12
2023 - 10 - 18
13
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
18
2023 - 09 - 25
12
2023 - 09 - 20
12
2023 - 09 - 13
13
2023 - 09 - 07
15
2023 - 08 - 23
12
2023 - 06 - 26
13
2023 - 06 - 15
12
2023 - 04 - 27
13
2023 - 04 - 25
13
2023 - 04 - 17
15
2023 - 03 - 27
12
2023 - 02 - 23
12
2023 - 01 - 30
16
2023 - 01 - 25
16
2023 - 01 - 04
13
2022 - 11 - 17
14
2022 - 10 - 12
14
2022 - 10 - 06
14
2022 - 09 - 15
12
2022 - 09 - 14
15
2022 - 08 - 22
13
2022 - 05 - 17
13
2022 - 05 - 03
13
2022 - 03 - 28
14
2022 - 01 - 24
16
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
14
2021 - 11 - 01
12
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
13
2021 - 10 - 04
12
2021 - 09 - 07
12
2021 - 06 - 29
12
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
13
2021 - 03 - 22
14
2020 - 12 - 21
14
2020 - 12 - 15
16
2020 - 12 - 02
12
2020 - 12 - 01
18
Crawled Time
02:00
1
08:00
1
12:00
2
13:15
1
14:00
2
16:00
1
19:00
1
20:00
1
22:00
1
Source
www.biospace.com
5
www.globenewswire.com
2
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
crawled date :
2021 - 04 - 30
save search
Sarepta Therapeutics to Share Clinical Update for 30 mg/kg arm of MOMENTUM Study for SRP-5051, Its Investigational PPMO for the Treatment of Duchenne Muscular Dystrophy
Published:
2021-04-30
(Crawled : 22:00)
- biospace.com/
SRPT
|
$117.885
0.51%
0.48%
550K
|
Health Technology
|
65.09%
|
O:
-0.43%
H:
1.54%
C:
-0.37%
treatment
duchenne
Worldwide Dry Eye Disease (DED) Industry to 2026 - by Disease, Treatment, End-user, Distribution Channel and Region
Published:
2021-04-30
(Crawled : 20:00)
- prnewswire.com
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
Email alert
Add to watchlist
dry eye
disease
treatment
eye
eye disease
distribution
Global Allergy Treatment Markets, 2020-2021 & Forecast to 2028: Increasing Adoption of Immunotherapy in Allergy Treatment & Developments in Food Allergy Treatments
Published:
2021-04-30
(Crawled : 19:00)
- prnewswire.com
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
food
treatment
immunotherapy
therapy
Worldwide Neurological Diseases Treatment Industry to 2029 - Featuring Novartis, GlaxoSmithKline and Bayer Among Others
Published:
2021-04-30
(Crawled : 16:00)
- prnewswire.com
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
8.19%
|
O:
-0.48%
H:
0.57%
C:
-0.44%
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
5.6%
|
O:
0.61%
H:
0.4%
C:
-1.03%
AZN
|
$68.53
0.39%
0.39%
3.2M
|
Health Technology
|
32.89%
|
O:
3.7%
H:
2.42%
C:
-0.38%
disease
treatment
neurological
Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN2A-DEEPRAX-562 Phase 2 clinical trial for treatment of DEEs expected to initiate in first half of 2022
Published:
2021-04-30
(Crawled : 14:00)
- biospace.com/
PRAX
|
$50.78
-3.11%
-3.6%
270K
|
Health Technology
|
57.6%
|
O:
-2.42%
H:
1.4%
C:
-2.48%
treatment
phase 2
drug
trial
designation
Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the Development of a Proposed Treatment for Xerostomia
Published:
2021-04-30
(Crawled : 14:00)
- biospace.com/
LNTH
|
$61.48
-0.41%
-0.39%
540K
|
Health Technology
|
161.39%
|
O:
-1.06%
H:
2.28%
C:
1.85%
treatment
gene therapy
therapy
gene therapies
Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN2A-DEE
Published:
2021-04-30
(Crawled : 13:15)
- globenewswire.com
PRAX
|
$50.78
-3.11%
-3.6%
270K
|
Health Technology
|
57.6%
|
O:
-2.42%
H:
1.4%
C:
-2.48%
treatment
drug
designation
Legend Biotech Announces Submission of European Marketing Authorisation Application for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published:
2021-04-30
(Crawled : 12:00)
- biospace.com/
LEGN
|
$48.83
-2.57%
-2.62%
1.4M
|
Health Technology
|
62.17%
|
O:
-0.37%
H:
0.8%
C:
0.33%
treatment
europe
therapy
car-t
biotech
iot
submission
cel
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab) as Adjuvant Treatment for Patients with Muscle-Invasive Urothelial Carcinoma
Published:
2021-04-30
(Crawled : 12:00)
- biospace.com/
BMY
|
$47.84
-0.87%
0.82%
9.9M
|
Health Technology
|
-23.26%
|
O:
-1.42%
H:
1.23%
C:
0.68%
food
treatment
drug
application
nivolumab
urothelial carcinoma
Analyzing COVID-19 Impact on Fracking Water Treatment Market | $ 1.12 Billion Growth Expected During 2021-2025 | Technavio
Published:
2021-04-30
(Crawled : 08:00)
- prnewswire.com
XYL
|
$126.22
-1.39%
0.0%
1.4M
|
Producer Manufacturing
|
12.43%
|
O:
-0.69%
H:
0.39%
C:
-0.75%
covid
treatment
growth
Eloxx Pharmaceuticals Adds Additional Treatment Arm to Ongoing Phase 2 Clinical Studies for Cystic Fibrosis
Published:
2021-04-29
(Crawled : 02:00)
- globenewswire.com
ELOX
|
$0.9625
-2.52%
-51.57%
93K
|
Health Technology
|
-54.08%
|
O:
-1.4%
H:
3.77%
C:
2.83%
treatment
phase 2
ongoing
fibrosis
cystic fibrosis
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.82
139.47%
56.82%
220M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.66
46.37%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
600K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.3442
18.28%
23.42%
290K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.